These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4783767)

  • 1. [Survival in primary cancers of the ovary in adult women. Analysis of 205 cases as a function of histology, staging and treatment].
    Robert HG; Dutranoy G; Scali P
    J Chir (Paris); 1973 Sep; 106(3):223-48. PubMed ID: 4783767
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian serous cystadenoma.
    Tarlowska L; Sikorowa L; Piatkowski Z
    Pol Med J; 1972; 11(2):368-79. PubMed ID: 5071524
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer of the ovary.
    Constable WC; Birrell WR; Truskett ID
    Surg Gynecol Obstet; 1969 Feb; 128(2):294-300. PubMed ID: 4180453
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
    Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
    Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consideration on prognosis of malignant ovarian tumor and influencing factors].
    Nakayama M; Yamabe T; Jimi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Sep; 23(9):869-72. PubMed ID: 5165752
    [No Abstract]   [Full Text] [Related]  

  • 11. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Super radical surgery of advanced ovarian cancers (stages III and IV)].
    Michel G; Castaigne D; Morice P; Lhommé C; Duviliard P
    Contracept Fertil Sex; 1997 Jun; 25(6):V-XI. PubMed ID: 9280543
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term follow-up of the ovarian malignant teratoma].
    Zhu GZ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):220-3, 253-4. PubMed ID: 8404306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
    Qiao YH; Cheng J; Guo RX
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors in epithelial neoplasm of the ovary. A multivariate analysis].
    Nazzal O; Suárez E; Olfos P; Campodónico I
    Rev Chil Obstet Ginecol; 1993; 58(4):281-91; discussion 291-2. PubMed ID: 7991845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian carcinoma from the current viewpoint].
    Ebeling K
    Z Arztl Fortbild (Jena); 1984; 78(6):215-24. PubMed ID: 6375168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer].
    Kreienberg R
    Gynakologe; 1986 Sep; 19(3):178-85. PubMed ID: 3770529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.